(Q47783590)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

title

NT-proBNP, a useful tool in hypertensive patients undergoing a diagnostic evaluation for primary aldosteronism (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Oliviero Olivieri

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

author name string

Francesca Pizzolo

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Francesco Zorzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Laura Chiecchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Letizia Consoli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Irene Aprili

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Patrizia Guarini

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Annalisa Castagna

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

Chiara Pavan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

publication date

13 August 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

page(s)

479-486

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12020-013-0028-6

7 March 2020

exact match

0 references

cites work

Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Update in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Primary aldosteronism: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Cardiovascular and renal damage in primary aldosteronism: outcomes after treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Aldosterone induces a vascular inflammatory phenotype in the rat heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Inappropriate left ventricular mass in patients with primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Cardiovascular outcomes in patients with primary aldosteronism after treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Eplerenone in patients with systolic heart failure and mild symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Comparison of B-type natriuretic peptides for assessment of cardiac function and prognosis in stable ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Characterization of resistant hypertension: association between resistant hypertension, aldosterone, and persistent intravascular volume expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Atrial and brain natriuretic peptides as markers of cardiac load and volume retention in primary aldosteronism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Rapid reversal of left ventricular hypertrophy and intracardiac volume overload in patients with resistant hypertension and hyperaldosteronism: a prospective clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Aldosterone to Renin ratio in a primary care setting: the Bussolengo study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Screening for primary aldosteronism in essential hypertension: diagnostic accuracy of the ratio of plasma aldosterone concentration to plasma renin activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Aldosterone and mineralocorticoid receptors: a personal reflection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Prevalence and characteristics of the metabolic syndrome in primary aldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Adipokines and cardiometabolic profile in primary hyperaldosteronism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12020-013-0028-6

Plasma atrial natriuretic peptide in primary aldosteronism (before and after treatment) and in Bartter's and Gordon's syndromes

21 January 2018

1 reference

12 December 2020

Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism

1 reference

12 December 2020

Effects of female sex hormones and contraceptive pill on the diagnostic work-up for primary aldosteronism

1 reference

12 December 2020

Effect of age on aldosterone/renin ratio (ARR) and comparison of screening accuracy of ARR plus elevated serum aldosterone concentration for primary aldosteronism screening in different age groups

1 reference

12 December 2020

Comparison of confirmatory tests for the diagnosis of primary aldosteronism

1 reference

12 December 2020

Brain natriuretic peptide is synthesized in the human adrenal medulla and its messenger ribonucleic acid expression along with that of atrial natriuretic peptide are enhanced in patients with primary aldosteronism

1 reference

12 December 2020

Left ventricular hypertrophy precedes other target-organ damage in primary aldosteronism

1 reference

12 December 2020

Further evaluation of saline infusion for the diagnosis of primary aldosteronism

1 reference

12 December 2020

1 reference

12 December 2020

The physiological and pathophysiological modulation of the endocrine function of the heart

1 reference

12 December 2020

Are women more at risk of false-positive primary aldosteronism screening and unnecessary suppression testing than men?

1 reference

12 December 2020

10.1007/S12020-013-0028-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23943252%20AND%20SRC:MED&resulttype=core&format=json

7 March 2020

1 reference